TY  - GEN
AU  - Díaz-Rubio,Eduardo
AU  - Pietrantonio,Filippo
AU  - de Braud,Filippo
TI  - Continuing single-agent bevacizumab as maintenance therapy after induction XELOX (or FOLFOX) plus bevacizumab in first-line treatment of metastatic colorectal cancer
SN  - 1549-490X
PY  - 2013///0604
KW  - Antibodies, Monoclonal, Humanized
KW  - economics
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Bevacizumab
KW  - Capecitabine
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Fluorouracil
KW  - Humans
KW  - Induction Chemotherapy
KW  - Leucovorin
KW  - Maintenance Chemotherapy
KW  - Neoplasm Metastasis
KW  - Organoplatinum Compounds
KW  - Oxaloacetates
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1634/theoncologist.2012-0075
ER  -